tirzepatide surmount-1 weight loss percent 72 weeks results Lilly released for SURMOUNT-2, a trial of in people with T2D and obesity or overweight at weeks: π10 mg: -13.4% BW π15 mg: -15.7% BW βοΈImportant: at Body composition changes during weight
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 7 - Oct 12




















